Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	steroid hydroxylase activity	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	5.81e-09	34	39	5	GO:0008395
GeneOntologyMolecularFunction	coumarin 7-hydroxylase activity	CYP2A6 CYP2A7 CYP2A13	6.89e-09	3	39	3	GO:0008389
GeneOntologyMolecularFunction	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	3.90e-08	49	39	5	GO:0016712
GeneOntologyMolecularFunction	arachidonate epoxygenase activity	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.28e-07	24	39	4	GO:0008392
GeneOntologyMolecularFunction	arachidonate monooxygenase activity	CYP2A6 CYP2A7 CYP2A13 CYP2B6	2.11e-07	27	39	4	GO:0008391
GeneOntologyMolecularFunction	aromatase activity	CYP2A6 CYP2A7 CYP2A13 CYP2B6	6.23e-07	35	39	4	GO:0070330
GeneOntologyMolecularFunction	monooxygenase activity	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	2.86e-06	115	39	5	GO:0004497
GeneOntologyMolecularFunction	dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity	ALG10B ALG10	3.72e-06	2	39	2	GO:0106073
GeneOntologyMolecularFunction	heme binding	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	1.19e-05	154	39	5	GO:0020037
GeneOntologyMolecularFunction	tetrapyrrole binding	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	1.62e-05	164	39	5	GO:0046906
GeneOntologyMolecularFunction	iron ion binding	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	1.71e-05	166	39	5	GO:0005506
GeneOntologyMolecularFunction	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	3.62e-05	194	39	5	GO:0016705
GeneOntologyMolecularFunction	G protein-coupled opioid receptor activity	OPRL1 OPRM1	7.76e-05	7	39	2	GO:0004985
GeneOntologyMolecularFunction	mechanosensitive monoatomic ion channel activity	TMC2 TMC5	5.58e-04	18	39	2	GO:0008381
GeneOntologyMolecularFunction	glucosyltransferase activity	ALG10B ALG10	8.38e-04	22	39	2	GO:0046527
GeneOntologyMolecularFunction	low-density lipoprotein particle receptor binding	LANCL1 SACS	2.00e-03	34	39	2	GO:0050750
GeneOntologyMolecularFunction	neuropeptide binding	OPRL1 OPRM1	2.37e-03	37	39	2	GO:0042923
GeneOntologyMolecularFunction	microfilament motor activity	MYH2 MYH4	2.50e-03	38	39	2	GO:0000146
GeneOntologyMolecularFunction	lipoprotein particle receptor binding	LANCL1 SACS	2.63e-03	39	39	2	GO:0070325
GeneOntologyMolecularFunction	voltage-gated calcium channel activity	TMC2 OPRM1	3.64e-03	46	39	2	GO:0005245
GeneOntologyMolecularFunction	gated channel activity	ANO5 TMC2 TMC5 OPRM1	3.99e-03	334	39	4	GO:0022836
GeneOntologyMolecularFunction	lipid transporter activity	SLCO1B3 ANO5 SPNS2	6.56e-03	196	39	3	GO:0005319
GeneOntologyMolecularFunction	Hsp70 protein binding	CYP2B6 SACS	6.73e-03	63	39	2	GO:0030544
GeneOntologyMolecularFunction	G protein-coupled receptor activity	OR2A14 LANCL1 OR2A5 OR52L2P OPRL1 OPRM1	6.92e-03	884	39	6	GO:0004930
GeneOntologyMolecularFunction	hexosyltransferase activity	B3GNT5 ALG10B ALG10	8.04e-03	211	39	3	GO:0016758
GeneOntologyBiologicalProcess	epoxygenase P450 pathway	CYP2A6 CYP2A7 CYP2A13 CYP2B6	7.79e-08	22	39	4	GO:0019373
GeneOntologyBiologicalProcess	phenylpropanoid metabolic process	CYP2A6 CYP2A7 CYP2A13	7.43e-07	10	39	3	GO:0009698
GeneOntologyBiologicalProcess	coumarin metabolic process	CYP2A6 CYP2A7 CYP2A13	7.43e-07	10	39	3	GO:0009804
GeneOntologyBiologicalProcess	xenobiotic metabolic process	SLCO1B3 CYP2A6 CYP2A7 CYP2A13 CYP2B6	6.64e-06	141	39	5	GO:0006805
GeneOntologyBiologicalProcess	arachidonate metabolic process	CYP2A6 CYP2A7 CYP2A13 CYP2B6	8.15e-06	68	39	4	GO:0019369
GeneOntologyBiologicalProcess	cellular response to xenobiotic stimulus	SLCO1B3 CYP2A6 CYP2A7 CYP2A13 CYP2B6	5.90e-05	222	39	5	GO:0071466
GeneOntologyBiologicalProcess	long-chain fatty acid metabolic process	CYP2A6 CYP2A7 CYP2A13 CYP2B6	8.70e-05	124	39	4	GO:0001676
GeneOntologyBiologicalProcess	unsaturated fatty acid metabolic process	CYP2A6 CYP2A7 CYP2A13 CYP2B6	9.84e-05	128	39	4	GO:0033559
GeneOntologyBiologicalProcess	sensory perception	OR2A14 OR2A5 TMC2 OR52L2P SPNS2 ALG10B ALG10 OPRL1 OPRM1	1.38e-04	1072	39	9	GO:0007600
GeneOntologyBiologicalProcess	heme metabolic process	SLCO1B3 CYP2A6 CYP2A13	1.45e-04	54	39	3	GO:0042168
GeneOntologyBiologicalProcess	icosanoid metabolic process	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.47e-04	142	39	4	GO:0006690
GeneOntologyBiologicalProcess	porphyrin-containing compound metabolic process	SLCO1B3 CYP2A6 CYP2A13	2.29e-04	63	39	3	GO:0006778
GeneOntologyBiologicalProcess	G protein-coupled opioid receptor signaling pathway	OPRL1 OPRM1	2.68e-04	13	39	2	GO:0038003
GeneOntologyBiologicalProcess	secondary metabolic process	CYP2A6 CYP2A7 CYP2A13	2.75e-04	67	39	3	GO:0019748
GeneOntologyBiologicalProcess	negative regulation of cAMP-mediated signaling	OPRL1 OPRM1	3.12e-04	14	39	2	GO:0043951
GeneOntologyBiologicalProcess	tetrapyrrole metabolic process	SLCO1B3 CYP2A6 CYP2A13	3.55e-04	73	39	3	GO:0033013
GeneOntologyBiologicalProcess	muscle filament sliding	MYH2 MYH4	3.60e-04	15	39	2	GO:0030049
GeneOntologyBiologicalProcess	olefinic compound metabolic process	CYP2A6 CYP2A7 CYP2A13 CYP2B6	3.63e-04	180	39	4	GO:0120254
GeneOntologyBiologicalProcess	sensory perception of sound	TMC2 SPNS2 ALG10B ALG10	5.21e-04	198	39	4	GO:0007605
GeneOntologyBiologicalProcess	negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway	OPRL1 OPRM1	5.23e-04	18	39	2	GO:0106072
GeneOntologyBiologicalProcess	actin-myosin filament sliding	MYH2 MYH4	5.23e-04	18	39	2	GO:0033275
GeneOntologyBiologicalProcess	pigment metabolic process	SLCO1B3 CYP2A6 CYP2A13	7.44e-04	94	39	3	GO:0042440
GeneOntologyBiologicalProcess	dolichol-linked oligosaccharide biosynthetic process	ALG10B ALG10	7.86e-04	22	39	2	GO:0006488
GeneOntologyBiologicalProcess	sympathetic nervous system development	PLXNA4 NF1	9.37e-04	24	39	2	GO:0048485
GeneOntologyBiologicalProcess	dolichol metabolic process	ALG10B ALG10	9.37e-04	24	39	2	GO:0019348
GeneOntologyBiologicalProcess	sensory perception of mechanical stimulus	TMC2 SPNS2 ALG10B ALG10	1.04e-03	238	39	4	GO:0050954
GeneOntologyBiologicalProcess	regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway	OPRL1 OPRM1	1.10e-03	26	39	2	GO:0106070
GeneOntologyCellularComponent	endoplasmic reticulum membrane	KDELR2 CYP2A6 CYP2A7 ANO5 CYP2A13 CYP2B6 CYP39A1 ALG10B ALG10 HHATL	9.65e-05	1293	39	10	GO:0005789
GeneOntologyCellularComponent	endoplasmic reticulum subcompartment	KDELR2 CYP2A6 CYP2A7 ANO5 CYP2A13 CYP2B6 CYP39A1 ALG10B ALG10 HHATL	1.00e-04	1299	39	10	GO:0098827
GeneOntologyCellularComponent	nuclear outer membrane-endoplasmic reticulum membrane network	KDELR2 CYP2A6 CYP2A7 ANO5 CYP2A13 CYP2B6 CYP39A1 ALG10B ALG10 HHATL	1.20e-04	1327	39	10	GO:0042175
GeneOntologyCellularComponent	muscle myosin complex	MYH2 MYH4	4.00e-04	16	39	2	GO:0005859
GeneOntologyCellularComponent	myosin filament	MYH2 MYH4	9.90e-04	25	39	2	GO:0032982
GeneOntologyCellularComponent	myosin II complex	MYH2 MYH4	1.24e-03	28	39	2	GO:0016460
GeneOntologyCellularComponent	cytoplasmic microtubule	CYP2A6 CYP2A7 CYP2A13	1.95e-03	133	39	3	GO:0005881
MousePheno	decreased intestinal cholesterol absorption	CYP2A6 CYP2A7 CYP2A13	9.55e-06	17	35	3	MP:0002647
MousePheno	abnormal intestinal cholesterol absorption	CYP2A6 CYP2A7 CYP2A13	1.36e-05	19	35	3	MP:0002645
MousePheno	abnormal xenobiotic pharmacokinetics	SLCO1B3 CYP2A6 CYP2A13	5.57e-05	30	35	3	MP:0008875
MousePheno	abnormal intestinal lipid absorption	CYP2A6 CYP2A7 CYP2A13	6.16e-05	31	35	3	MP:0005342
MousePheno	abnormal cochlear hair cell physiology	TMC2 ALG10B ALG10	1.33e-04	40	35	3	MP:0004432
MousePheno	abnormal bile salt homeostasis	CYP2A6 CYP2A7 CYP2A13	2.16e-04	47	35	3	MP:0005365
MousePheno	abnormal hair cell physiology	TMC2 ALG10B ALG10	2.45e-04	49	35	3	MP:0003879
MousePheno	impaired behavioral response to morphine	OPRL1 OPRM1	2.71e-04	10	35	2	MP:0009757
MousePheno	absent cochlear microphonics	ALG10B ALG10	2.71e-04	10	35	2	MP:0004413
MousePheno	abnormal intestinal absorption	CYP2A6 CYP2A7 CYP2A13	4.25e-04	59	35	3	MP:0001666
MousePheno	bleb	ALG10B ALG10	4.67e-04	13	35	2	MP:0008854
MousePheno	abnormal behavioral response to morphine	OPRL1 OPRM1	4.67e-04	13	35	2	MP:0020159
Domain	Cyt_P450_E_grp-I_CYP2A-like	CYP2A6 CYP2A7 CYP2A13	3.10e-08	4	38	3	IPR008067
Domain	CYTOCHROME_P450	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	1.03e-07	57	38	5	PS00086
Domain	-	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	1.12e-07	58	38	5	1.10.630.10
Domain	p450	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	1.12e-07	58	38	5	PF00067
Domain	Cyt_P450	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	1.34e-07	60	38	5	IPR001128
Domain	Cyt_P450_E_grp-I	CYP2A6 CYP2A7 CYP2A13 CYP2B6	2.04e-06	45	38	4	IPR002401
Domain	Cyt_P450_CS	CYP2A6 CYP2A7 CYP2A13 CYP2B6	3.97e-06	53	38	4	IPR017972
Domain	Alg10	ALG10B ALG10	4.03e-06	2	38	2	IPR016900
Domain	DIE2_ALG10	ALG10B ALG10	4.03e-06	2	38	2	PF04922
Domain	Opioid_rcpt	OPRL1 OPRM1	2.41e-05	4	38	2	IPR001418
Domain	TMC	TMC2 TMC5	1.12e-04	8	38	2	PF07810
Domain	TMC	TMC2 TMC5	1.12e-04	8	38	2	IPR012496
Domain	Myosin_N	MYH2 MYH4	4.16e-04	15	38	2	IPR004009
Domain	Myosin_N	MYH2 MYH4	4.16e-04	15	38	2	PF02736
Domain	Myosin_tail_1	MYH2 MYH4	6.04e-04	18	38	2	PF01576
Domain	Myosin_tail	MYH2 MYH4	6.04e-04	18	38	2	IPR002928
Domain	Myosin-like_IQ_dom	MYH2 MYH4	6.74e-04	19	38	2	IPR027401
Domain	-	MYH2 MYH4	6.74e-04	19	38	2	4.10.270.10
Domain	MYOSIN_MOTOR	MYH2 MYH4	2.71e-03	38	38	2	PS51456
Domain	Myosin_head	MYH2 MYH4	2.71e-03	38	38	2	PF00063
Domain	Myosin_head_motor_dom	MYH2 MYH4	2.71e-03	38	38	2	IPR001609
Domain	MYSc	MYH2 MYH4	2.71e-03	38	38	2	SM00242
Domain	ARM-type_fold	URB1 NF1 ARMH3 PI4KA	4.84e-03	339	38	4	IPR016024
Domain	IQ	MYH2 MYH4	9.17e-03	71	38	2	PF00612
Domain	IQ	MYH2 MYH4	1.18e-02	81	38	2	SM00015
Domain	Rho_GTPase_activation_prot	PLXNA4 NF1	1.38e-02	88	38	2	IPR008936
Domain	IQ_motif_EF-hand-BS	MYH2 MYH4	1.44e-02	90	38	2	IPR000048
Domain	IQ	MYH2 MYH4	1.53e-02	93	38	2	PS50096
Domain	MFS	SLCO1B3 SPNS2	2.03e-02	108	38	2	PS50850
Pathway	REACTOME_CYP2E1_REACTIONS	CYP2A6 CYP2A7 CYP2A13 CYP2B6	5.44e-09	11	30	4	M27130
Pathway	REACTOME_CYP2E1_REACTIONS	CYP2A6 CYP2A7 CYP2A13 CYP2B6	8.15e-09	12	30	4	MM14847
Pathway	REACTOME_FATTY_ACIDS	CYP2A6 CYP2A7 CYP2A13 CYP2B6	4.99e-08	18	30	4	MM14841
Pathway	REACTOME_XENOBIOTICS	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.43e-07	23	30	4	M5372
Pathway	WP_OXIDATION_BY_CYTOCHROME_P450	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	1.83e-07	62	30	5	M39653
Pathway	REACTOME_XENOBIOTICS	CYP2A6 CYP2A7 CYP2A13 CYP2B6	2.04e-07	25	30	4	MM14846
Pathway	REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	2.15e-07	64	30	5	M5650
Pathway	REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	2.51e-07	66	30	5	MM14839
Pathway	REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	2.44e-06	104	30	5	M738
Pathway	REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	2.56e-06	105	30	5	MM14842
Pathway	REACTOME_FATTY_ACIDS	CYP2A7 CYP2A13 CYP2B6	3.89e-06	15	30	3	M27126
Pathway	REACTOME_BIOLOGICAL_OXIDATIONS	CYP2A6 CYP2A7 BPNT2 CYP2A13 CYP2B6 CYP39A1	5.71e-06	219	30	6	MM14838
Pathway	REACTOME_BIOLOGICAL_OXIDATIONS	CYP2A6 CYP2A7 BPNT2 CYP2A13 CYP2B6 CYP39A1	5.86e-06	220	30	6	M10320
Pathway	KEGG_RETINOL_METABOLISM	CYP2A6 CYP2A7 CYP2A13 CYP2B6	9.69e-06	64	30	4	M9488
Pathway	KEGG_DRUG_METABOLISM_CYTOCHROME_P450	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.55e-05	72	30	4	M9257
Pathway	WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	3.82e-05	183	30	5	M39588
Pathway	KEGG_MEDICUS_ENV_FACTOR_NNK_TO_DNA_ADDUCTS	CYP2A6 CYP2A13	4.36e-05	5	30	2	M47808
Pathway	WP_NICOTINE_METABOLISM_IN_LIVER_CELLS	CYP2A6 CYP2B6	6.53e-05	6	30	2	M39600
Pathway	KEGG_DRUG_METABOLISM_OTHER_ENZYMES	CYP2A6 CYP2A7 CYP2A13	1.69e-04	51	30	3	M17726
Pathway	KEGG_MEDICUS_REFERENCE_N_GLYCAN_PRECURSOR_BIOSYNTHESIS_ALG6_TO_OST	ALG10B ALG10	2.38e-04	11	30	2	M47614
Pathway	WP_VALPROIC_ACID_PATHWAY	CYP2A6 CYP2B6	2.85e-04	12	30	2	M39371
Pathway	REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION	CYP2A6 CYP2A13	1.38e-03	26	30	2	MM15190
Pathway	WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY	CYP2A6 CYP2B6	1.96e-03	31	30	2	M39476
Pathway	WP_PREGNANE_X_RECEPTOR_PATHWAY	CYP2A6 CYP2B6	2.09e-03	32	30	2	M39567
Pathway	WP_OPIOID_RECEPTOR_PATHWAYS	OPRL1 OPRM1	3.41e-03	41	30	2	M48338
Pathway	REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM	SLCO1B3 CYP39A1	3.92e-03	44	30	2	M499
Pathway	REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM	SLCO1B3 CYP39A1	4.09e-03	45	30	2	MM14751
Pathway	KEGG_N_GLYCAN_BIOSYNTHESIS	ALG10B ALG10	4.28e-03	46	30	2	M11079
Pubmed	Two steroid 15 alpha-hydroxylase genes and a homologous gene family in mice.	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.50e-12	4	40	4	1970547
Pubmed	Zinc Fingers and Homeoboxes 2 (Zhx2) Regulates Sexually Dimorphic Cyp Gene Expression in the Adult Mouse Liver.	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	9.51e-12	17	40	5	27197076
Pubmed	A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles.	CYP2A6 CYP2A7 CYP2A13 CYP2B6	2.25e-11	6	40	4	7668294
Pubmed	Organization and evolution of the cytochrome P450 CYP2A-2B-2F subfamily gene cluster on human chromosome 19.	CYP2A6 CYP2A7 CYP2A13 CYP2B6	2.25e-11	6	40	4	8587134
Pubmed	Organization and evolution of the Cyp2 gene cluster on mouse chromosome 7, and comparison with the syntenic human cluster.	CYP2A6 CYP2A7 CYP2A13 CYP2B6	5.23e-11	7	40	4	14630516
Pubmed	Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition.	CYP2A6 CYP2A7 CYP2A13	1.41e-09	3	40	3	31645370
Pubmed	Rip locus: regulation of female-specific isozyme (I-P-450(16 alpha) of testosterone 16 alpha-hydroxylase in mouse liver, chromosome localization, and cloning of P-450 cDNA.	CYP2A6 CYP2A13 CYP2B6	1.41e-09	3	40	3	3219345
Pubmed	Reciprocal regulation of sex-dependent expression of testosterone 15 alpha-hydroxylase (P-450(15 alpha)) in liver and kidney of male mice by androgen. Evidence for a single gene.	CYP2A6 CYP2A7 CYP2A13	1.41e-09	3	40	3	3346244
Pubmed	Alteration of mouse cytochrome P450coh substrate specificity by mutation of a single amino-acid residue.	CYP2A6 CYP2A7 CYP2A13	1.41e-09	3	40	3	2733794
Pubmed	A trans-acting locus regulates transcriptional repression of the female-specific steroid 15 alpha-hydroxylase gene in male mice.	CYP2A6 CYP2A7 CYP2A13	1.41e-09	3	40	3	8297477
Pubmed	Lack of the steroid 15 alpha-hydroxylase gene (Cyp2a-4) in wild mouse strain Mus spretus: rapid evolution of the P450 gene superfamily.	CYP2A6 CYP2A7 CYP2A13	1.41e-09	3	40	3	8188299
Pubmed	Site-directed mutagenesis of mouse steroid 7 alpha-hydroxylase (cytochrome P-450(7) alpha): role of residue-209 in determining steroid-cytochrome P-450 interaction.	CYP2A6 CYP2A7 CYP2A13	1.41e-09	3	40	3	8484736
Pubmed	Comparison of hamster and mouse reveals interspecies differences in the regulation of hepatic CYP2A isozymes.	CYP2A6 CYP2A7 CYP2A13	1.41e-09	3	40	3	8250953
Pubmed	The structure and characterization of type I P-450(15) alpha gene as major steroid 15 alpha-hydroxylase and its comparison with type II P-450(15) alpha gene.	CYP2A6 CYP2A7 CYP2A13	1.41e-09	3	40	3	2703500
Pubmed	Cerium-induced strain-dependent increase in Cyp2a-4/5 (cytochrome P4502a-4/5) expression in the liver and kidneys of inbred mice.	CYP2A6 CYP2A7 CYP2A13	1.41e-09	3	40	3	1417950
Pubmed	Impact of nicotine metabolism on nicotine's pharmacological effects and behavioral responses: insights from a Cyp2a(4/5)bgs-null mouse.	CYP2A6 CYP2A7 CYP2A13	1.41e-09	3	40	3	24045421
Pubmed	Highly homologous mouse Cyp2a4 and Cyp2a5 genes are differentially expressed in the liver and both express long non-coding antisense RNAs.	CYP2A6 CYP2A7 CYP2A13	1.41e-09	3	40	3	32987105
Pubmed	Close linkage of the cytochrome P450IIA gene subfamily (Cyp2a) to Cyp2b and Coh on mouse chromosome 7.	CYP2A6 CYP2A13 CYP2B6	1.41e-09	3	40	3	1973143
Pubmed	Alteration of the substrate specificity of mouse 2A P450s by the identity of residue-209: steroid-binding site and orientation.	CYP2A6 CYP2A7 CYP2A13	1.41e-09	3	40	3	22217847
Pubmed	Mouse steroid 15 alpha-hydroxylase gene family: identification of type II P-450(15)alpha as coumarin 7-hydroxylase.	CYP2A6 CYP2A7 CYP2A13	1.41e-09	3	40	3	2765478
Pubmed	Sexual dimorphism of testosterone 15 alpha-hydroxylase mRNA levels in mouse liver. cDNA cloning and regulation.	CYP2A6 CYP2A7 CYP2A13	1.41e-09	3	40	3	2415518
Pubmed	Differential distribution of CYP2A6 and CYP2A13 in the human respiratory tract.	CYP2A6 CYP2A7 CYP2A13	1.41e-09	3	40	3	22890016
Pubmed	Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues.	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	1.63e-09	44	40	5	12745259
Pubmed	Establishment and analysis of a mouse model that regulates sex-related differences in liver drug metabolism.	CYP2A6 CYP2A7 CYP2A13 CYP2B6	2.03e-09	15	40	4	29968852
Pubmed	Transcriptional regulation by HNF-4 of the steroid 15alpha-hydroxylase P450 (Cyp2a-4) gene in mouse liver.	CYP2A6 CYP2A7 CYP2A13	5.63e-09	4	40	3	9408084
Pubmed	Circadian expression of the steroid 15 alpha-hydroxylase (Cyp2a4) and coumarin 7-hydroxylase (Cyp2a5) genes in mouse liver is regulated by the PAR leucine zipper transcription factor DBP.	CYP2A6 CYP2A7 CYP2A13	5.63e-09	4	40	3	10490589
Pubmed	A DNA methylation site in the male-specific P450 (Cyp 2d-9) promoter and binding of the heteromeric transcription factor GABP.	CYP2A6 CYP2A7 CYP2A13	5.63e-09	4	40	3	7565685
Pubmed	Possible involvement of nuclear factor erythroid 2-related factor 2 in the gene expression of Cyp2b10 and Cyp2a5.	CYP2A6 CYP2A13 CYP2B6	5.63e-09	4	40	3	24494203
Pubmed	Molecular genetics of the human cytochrome P450 monooxygenase superfamily.	CYP2A6 CYP2A7 CYP2A13 CYP2B6	7.17e-09	20	40	4	9890157
Pubmed	Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants.	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	1.78e-08	70	40	5	15128046
Pubmed	Resveratrol improves health and survival of mice on a high-calorie diet.	CYP2A6 CYP2A7 CYP2A13 CYP2B6	2.20e-08	26	40	4	17086191
Pubmed	Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses.	CYP2A6 CYP2A7 CYP2A13	4.92e-08	7	40	3	9630227
Pubmed	Maternal DHA intake in mice increased DHA metabolites in the pup brain and ameliorated MeHg-induced behavioral disorder.	CYP2A6 CYP2A7 CYP2A13	1.18e-07	9	40	3	37838304
Pubmed	Novel DNA sequence variations of cytochrome P450 genes in the Han Chinese population.	CYP2A6 CYP2A13 CYP2B6	5.08e-07	14	40	3	19290787
Pubmed	Mitochondrial phosphoproteome revealed by an improved IMAC method and MS/MS/MS.	SLCO1B3 CYP2A6 CYP2A7 CYP2A13	5.67e-07	57	40	4	17208939
Pubmed	Effects of spinally administered bifunctional nociceptin/orphanin FQ peptide receptor/μ-opioid receptor ligands in mouse models of neuropathic and inflammatory pain.	OPRL1 OPRM1	1.29e-06	2	40	2	23652222
Pubmed	Characterization of a novel CYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity.	CYP2A6 CYP2A7	1.29e-06	2	40	2	12325023
Pubmed	Race/Ethnicity and the Pharmacogenetics of Reported Suicidality With Efavirenz Among Clinical Trials Participants.	CYP2A6 CYP2B6	1.29e-06	2	40	2	28931220
Pubmed	Heterodimerization of opioid receptor-like 1 and mu-opioid receptors impairs the potency of micro receptor agonist.	OPRL1 OPRM1	1.29e-06	2	40	2	15748148
Pubmed	Evaluation of inhibition selectivity for human cytochrome P450 2A enzymes.	CYP2A6 CYP2A13	1.29e-06	2	40	2	22696418
Pubmed	Suppressed hepatocyte proliferation via a ROS-HNE-P21 pathway is associated with nicotine- and cotinine-enhanced alcoholic fatty liver in mice.	CYP2A6 CYP2A13	1.29e-06	2	40	2	30876690
Pubmed	CYP2A5 induction and hepatocellular stress: an adaptive response to perturbations of heme homeostasis.	CYP2A6 CYP2A13	1.29e-06	2	40	2	21395539
Pubmed	Species differences in coumarin metabolism: a molecular modelling evaluation of CYP2A interactions.	CYP2A6 CYP2A13	1.29e-06	2	40	2	12162851
Pubmed	Molecular characterization of the murine Coh locus: an amino acid difference at position 117 confers high and low coumarin 7-hydroxylase activity in P450coh.	CYP2A6 CYP2A13	1.29e-06	2	40	2	1302041
Pubmed	Structural alteration of mouse P450coh by mutation of glycine-207 to proline: spin equilibrium, enzyme kinetics, and heat sensitivity.	CYP2A6 CYP2A13	1.29e-06	2	40	2	8395817
Pubmed	Absence of cytochrome P450 2A5 enhances alcohol-induced liver injury in mice.	CYP2A6 CYP2A13	1.29e-06	2	40	2	25804444
Pubmed	Effect of pyrazole, cobalt and phenobarbital on mouse liver cytochrome P-450 2a-4/5 (Cyp2a-4/5) expression.	CYP2A6 CYP2A13	1.29e-06	2	40	2	1520280
Pubmed	Gene-gene interactions between CYP2B6 and CYP2A6 in nicotine metabolism.	CYP2A6 CYP2B6	1.29e-06	2	40	2	18004205
Pubmed	Role of CYP2A13 in the bioactivation and lung tumorigenicity of the tobacco-specific lung procarcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone: in vivo studies using a CYP2A13-humanized mouse model.	CYP2A6 CYP2A13	1.29e-06	2	40	2	23917075
Pubmed	Nicotine enhances alcoholic fatty liver in mice: Role of CYP2A5.	CYP2A6 CYP2A13	1.29e-06	2	40	2	30222954
Pubmed	CYP2A7 polymorphic alleles confound the genotyping of CYP2A6*4A allele.	CYP2A6 CYP2A7	1.29e-06	2	40	2	16636685
Pubmed	Up-regulation of CYP2A5 expression by porphyrinogenic agents in mouse liver.	CYP2A6 CYP2A13	1.29e-06	2	40	2	7543189
Pubmed	Genomic Landscape of Experimental Bladder Cancer in Rodents and Its Application to Human Bladder Cancer: Gene Amplification and Potential Overexpression of Cyp2a5/CYP2A6 Are Associated with the Invasive Phenotype.	CYP2A6 CYP2A13	1.29e-06	2	40	2	27902773
Pubmed	Genetic variants in CYP2B6 and CYP2A6 explain interindividual variation in efavirenz plasma concentrations of HIV-infected children with diverse ethnic origin.	CYP2A6 CYP2B6	1.29e-06	2	40	2	28886044
Pubmed	Characterization and regulation of sex-specific mouse steroid hydroxylase genes.	CYP2A6 CYP2A13	1.29e-06	2	40	2	2372744
Pubmed	The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes.	CYP2A6 CYP2A7	1.29e-06	2	40	2	2322567
Pubmed	Metabolic effects of CYP2A6 and CYP2A13 on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced gene mutation--a mammalian cell-based mutagenesis approach.	CYP2A6 CYP2A13	1.29e-06	2	40	2	21473878
Pubmed	The CYP2A gene subfamily: species differences, regulation, catalytic activities and role in chemical carcinogenesis.	CYP2A6 CYP2A13	1.29e-06	2	40	2	7581481
Pubmed	Circadian Regulation of Hepatic Cytochrome P450 2a5 by Peroxisome Proliferator-Activated Receptor γ.	CYP2A6 CYP2A13	1.29e-06	2	40	2	30154104
Pubmed	Expression of CYP2A genes in human liver and extrahepatic tissues.	CYP2A7 CYP2A13	1.29e-06	2	40	2	10353262
Pubmed	Expression and alternative splicing of the cytochrome P-450 CYP2A7.	CYP2A6 CYP2A7	1.29e-06	2	40	2	7864805
Pubmed	Interstrain differences in the expression and activity of Cyp2a5 in the mouse liver.	CYP2A6 CYP2A13	1.29e-06	2	40	2	28298240
Pubmed	Implications of OPRM1 and CYP2B6 variants on treatment outcomes in methadone-maintained patients in Ontario: Exploring sex differences.	CYP2B6 OPRM1	1.29e-06	2	40	2	34910759
Pubmed	Genetic polymorphisms for a phenobarbital-inducible cytochrome P-450 map to the Coh locus in mice.	CYP2A6 CYP2A13	1.29e-06	2	40	2	6309775
Pubmed	CYP2B6 (c.516G-->T) and CYP2A6 (9B and/or 17) polymorphisms are independent predictors of efavirenz plasma concentrations in HIV-infected patients.	CYP2A6 CYP2B6	1.29e-06	2	40	2	19371316
Pubmed	Mechanism-based inhibition of cytochrome P450 (CYP)2A6 by chalepensin in recombinant systems, in human liver microsomes and in mice in vivo.	CYP2A6 CYP2A13	1.29e-06	2	40	2	21418183
Pubmed	Role of CYP2A5 in the bioactivation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mice.	CYP2A6 CYP2A13	1.29e-06	2	40	2	22262919
Pubmed	Elevated methylation of OPRM1 and OPRL1 genes in Alzheimer's disease.	OPRL1 OPRM1	1.29e-06	2	40	2	30152845
Pubmed	Modulation of cytochrome P450 2A5 activity by lipopolysaccharide: low-dose effects and non-monotonic dose-response relationship.	CYP2A6 CYP2A13	1.29e-06	2	40	2	25635819
Pubmed	Genetic variation between mice in their metabolism of coumarin and its derivatives.	CYP2A6 CYP2A13	1.29e-06	2	40	2	566237
Pubmed	Temporal spatial expression and function of non-muscle myosin II isoforms IIA and IIB in scar remodeling.	MYH2 MYH4	1.29e-06	2	40	2	21102503
Pubmed	CYP2B6 and OPRM1 gene variations predict methadone-related deaths.	CYP2B6 OPRM1	1.29e-06	2	40	2	21158011
Pubmed	Role of CYP2A5 in the clearance of nicotine and cotinine: insights from studies on a Cyp2a5-null mouse model.	CYP2A6 CYP2A13	1.29e-06	2	40	2	19923441
Pubmed	Effects of lipopolysaccharide-stimulated inflammation and pyrazole-mediated hepatocellular injury on mouse hepatic Cyp2a5 expression.	CYP2A6 CYP2A13	1.29e-06	2	40	2	12499123
Pubmed	Identification and characterization of a 44 kDa protein that binds specifically to the 3'-untranslated region of CYP2a5 mRNA: inducibility, subcellular distribution and possible role in mRNA stabilization.	CYP2A6 CYP2A13	1.29e-06	2	40	2	8611142
Pubmed	Function and regulation of the Cyp2a5/CYP2A6 genes in response to toxic insults in the liver.	CYP2A6 CYP2A13	1.29e-06	2	40	2	22497566
Pubmed	Coumarin toxicity in different strains of mice.	CYP2A6 CYP2A13	1.29e-06	2	40	2	665441
Pubmed	Determinants of the rate of nicotine metabolism and effects on smoking behavior.	CYP2A6 CYP2B6	1.29e-06	2	40	2	17015050
Pubmed	Essential role of the cytochrome P450 enzyme CYP2A5 in olfactory mucosal toxicity of naphthalene.	CYP2A6 CYP2A13	1.29e-06	2	40	2	24104196
Pubmed	OPRM1 and CYP2B6 gene variants as risk factors in methadone-related deaths.	CYP2B6 OPRM1	1.29e-06	2	40	2	20668445
Pubmed	The role of CYP2A5 in liver injury and fibrosis: chemical-specific difference.	CYP2A6 CYP2A13	1.29e-06	2	40	2	26363552
Pubmed	Mouse liver P450Coh: genetic regulation of the pyrazole-inducible enzyme and comparison with other P450 isoenzymes.	CYP2A6 CYP2A13	1.29e-06	2	40	2	2712571
Pubmed	Catalog of 680 variations among eight cytochrome p450 ( CYP) genes, nine esterase genes, and two other genes in the Japanese population.	CYP2A6 CYP2A13 CYP2B6	1.35e-06	19	40	3	12721789
Pubmed	Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation.	MYH2 MYH4	3.87e-06	3	40	2	26059207
Pubmed	Coactivator PGC-1alpha regulates the fasting inducible xenobiotic-metabolizing enzyme CYP2A5 in mouse primary hepatocytes.	CYP2A6 CYP2A13	3.87e-06	3	40	2	18602936
Pubmed	Expression of cytochrome P450 2A5 in a glucose-6-phosphate dehydrogenase-deficient mouse model of oxidative stress.	CYP2A6 CYP2A13	3.87e-06	3	40	2	18068688
Pubmed	CYP2A6/2A7 and CYP2E1 expression in human oesophageal mucosa: regional and inter-individual variation in expression and relevance to nitrosamine metabolism.	CYP2A6 CYP2A7	3.87e-06	3	40	2	11960914
Pubmed	Zfp30, a KRAB domain containing zinc finger protein gene, maps to mouse chromosome 7.	CYP2A6 CYP2A13	3.87e-06	3	40	2	7849402
Pubmed	A point mutation in the gene for asparagine-linked glycosylation 10B (Alg10b) causes nonsyndromic hearing impairment in mice (Mus musculus).	ALG10B ALG10	3.87e-06	3	40	2	24303013
Pubmed	Mechanisms of olfactory toxicity of the herbicide 2,6-dichlorobenzonitrile: essential roles of CYP2A5 and target-tissue metabolic activation.	CYP2A6 CYP2A13	3.87e-06	3	40	2	20840855
Pubmed	Ethanol induction of CYP2A5: role of CYP2E1-ROS-Nrf2 pathway.	CYP2A6 CYP2A13	3.87e-06	3	40	2	22552773
Pubmed	Maximum velocity of shortening in relation to myosin isoform composition in single fibres from human skeletal muscles.	MYH2 MYH4	3.87e-06	3	40	2	8145163
Pubmed	Limited heme synthesis in porphobilinogen deaminase-deficient mice impairs transcriptional activation of specific cytochrome P450 genes by phenobarbital.	CYP2A6 CYP2A13	3.87e-06	3	40	2	11106424
Pubmed	Common and Distinct Interactions of Chemical Inhibitors with Cytochrome P450 CYP1A2, CYP2A6 and CYP2B6 Enzymes.	CYP2A6 CYP2B6	3.87e-06	3	40	2	26648056
Pubmed	Regulation of CYP2A5 gene by the transcription factor nuclear factor (erythroid-derived 2)-like 2.	CYP2A6 CYP2A13	3.87e-06	3	40	2	17303623
Pubmed	ZEB1 imposes a temporary stage-dependent inhibition of muscle gene expression and differentiation via CtBP-mediated transcriptional repression.	MYH2 MYH4	3.87e-06	3	40	2	23339872
Pubmed	CYP2B6, CYP2A6 and UGT2B7 genetic polymorphisms are predictors of efavirenz mid-dose concentration in HIV-infected patients.	CYP2A6 CYP2B6	3.87e-06	3	40	2	19779319
Pubmed	A novel defensive mechanism against acetaminophen toxicity in the mouse lateral nasal gland: role of CYP2A5-mediated regulation of testosterone homeostasis and salivary androgen-binding protein expression.	CYP2A6 CYP2A13	3.87e-06	3	40	2	21252290
Pubmed	Mitochondrial targeting of bilirubin regulatory enzymes: An adaptive response to oxidative stress.	CYP2A6 CYP2A13	3.87e-06	3	40	2	25478736
Pubmed	The myosin alkali light chain proteins and their genes.	MYH2 MYH4	3.87e-06	3	40	2	3904738
Interaction	CYP2A7 interactions	CYP2A6 CYP2A7 CYP2A13	5.23e-09	3	36	3	int:CYP2A7
Interaction	CYP2A13 interactions	CYP2A7 CYP2A13	4.63e-05	6	36	2	int:CYP2A13
Interaction	C3orf18 interactions	NF1 ARMH3 SACS PI4KA	5.15e-05	115	36	4	int:C3orf18
Interaction	CYP2A6 interactions	CYP2A6 CYP2A7	1.11e-04	9	36	2	int:CYP2A6
Interaction	RAB39B interactions	BPNT2 CTLA4 OPRL1	1.36e-04	56	36	3	int:RAB39B
Interaction	SPPL3 interactions	MYH4 B3GNT5 CYP39A1 PI4KA SPNS2 HHATL OPRL1 OPRM1	1.37e-04	886	36	8	int:SPPL3
Cytoband	19q13.2	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.30e-05	164	40	4	19q13.2
Cytoband	7q35	OR2A14 OR2A5	1.07e-03	55	40	2	7q35
Cytoband	Ensembl 112 genes in cytogenetic band chr7q35	OR2A14 OR2A5	1.53e-03	66	40	2	chr7q35
Cytoband	Ensembl 112 genes in cytogenetic band chr17p13	MYH2 MYH4 SPNS2	3.41e-03	346	40	3	chr17p13
Cytoband	17p13.1	MYH2 MYH4	4.79e-03	118	40	2	17p13.1
GeneFamily	Cytochrome P450 family 2	CYP2A6 CYP2A7 CYP2A13 CYP2B6	2.33e-07	35	28	4	1001
GeneFamily	Alpha-1,2-glucosyltransferases	ALG10B ALG10	2.31e-06	2	28	2	448
GeneFamily	Opioid receptors	OPRL1 OPRM1	1.39e-05	4	28	2	245
GeneFamily	Transmembrane channel likes	TMC2 TMC5	6.44e-05	8	28	2	1135
GeneFamily	Myosin heavy chains	MYH2 MYH4	2.40e-04	15	28	2	1098
GeneFamily	Olfactory receptors, family 2	OR2A14 OR2A5	1.32e-02	113	28	2	149
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	TMEM225 SACS	3.18e-02	181	28	2	694
Coexpression	WENG_POR_DOSAGE	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.24e-07	30	40	4	MM1199
Coexpression	WENG_POR_TARGETS_LIVER_UP	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.29e-06	53	40	4	MM1203
Coexpression	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP	CYP2A6 CYP2A7 CYP2A13 NF1 OPRM1	5.19e-05	267	40	5	MM984
CoexpressionAtlas	liver	SLCO1B3 CYP2A6 CYP2A7 CYP2B6 CYP39A1 KLKB1	4.80e-05	419	34	6	liver
ToppCell	Adult-Epithelial-club_cell\|Adult / Lineage, Cell type, age group and donor	PLXNA4 CYP2A7 CYP2B6 TMC5 SPNS2	6.53e-07	190	39	5	756bff697d30aec56c0ebfca94295f084a15bf37
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.4\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SLCO1B3 CYP2A7 CYP2A13 CYP2B6 TMC5	6.70e-07	191	39	5	e96184aee03175fd9f1da11fa2b89d95ba58b817
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CYP2A6 CYP2A7 CYP2A13 CYP2B6 TMC5	7.05e-07	193	39	5	605fc2a25ed6846fb283b2918cfed98df6039d6b
ToppCell	Parenchyma_Control_(B.)-Epithelial-TX-Club\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	CYP2A6 CYP2A7 CYP2A13 CYP2B6 TMC5	8.20e-07	199	39	5	111cfd589ec6795075d8d88d7664bfb23eba5bf6
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Club-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CYP2A6 CYP2A7 CYP2A13 CYP2B6 TMC5	8.20e-07	199	39	5	d583290a1d288b749ad17bc501c1487268c6551c
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Club\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CYP2A6 CYP2A7 CYP2A13 CYP2B6 TMC5	8.20e-07	199	39	5	2b17694cffbec28a2c8f165dfcff6bab94aa0f4c
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CYP2A6 CYP2A13 CYP2B6 TMC5	1.07e-05	157	39	4	c43f2e1ea53b375a7432f17f87cfef3b2261003d
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CYP2A6 CYP2A7 CYP2B6 TMC5	1.21e-05	162	39	4	5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-skeletal_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH2 MYH4 ANO5 HHATL	1.60e-05	174	39	4	4a6e04b4f12b87c15fa1409989cbe32c43736369
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.60e-05	174	39	4	42f2ba54b4ea4c62482582b0ccdadffae0a5eb4a
ToppCell	Adult-Epithelial-club_cell-D175\|Adult / Lineage, Cell type, age group and donor	PLXNA4 CYP2B6 TMC5 SPNS2	1.71e-05	177	39	4	d652b7d84fe6aa38319d8d5adc72c70441bd0088
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CYP2A6 CYP2A7 CYP2B6 SPNS2	1.75e-05	178	39	4	f5ed4a6e3eb8056b1be1fb311021710c95bdf888
ToppCell	Adult-Epithelial-club_cell-D122\|Adult / Lineage, Cell type, age group and donor	CYP2A6 CYP2A7 CYP2B6 SPNS2	1.75e-05	178	39	4	35a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17
ToppCell	Control-Epithelial_cells-Airway_club\|Control / group, cell type (main and fine annotations)	CYP2A6 CYP2A7 CYP2B6 TMC5	1.87e-05	181	39	4	c755d23dd9aabc717dc73e2b3fa99a1f751e6507
ToppCell	Control-Epithelial-Club\|Epithelial / Disease state, Lineage and Cell class	CYP2A6 CYP2A7 CYP2A13 CYP2B6	2.03e-05	185	39	4	6814b3c94c7558443c038a227b5c8563d2cfeac4
ToppCell	Control-Epithelial-Club\|World / Disease state, Lineage and Cell class	CYP2A6 CYP2A7 CYP2B6 TMC5	2.08e-05	186	39	4	9798428691408e17ff2af2fe2d1b345f074d67e4
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CYP2A6 CYP2A13 CYP2B6 TMC5	2.30e-05	191	39	4	cd709bbcd320373468ea7f058ee5fda8a067b5d0
ToppCell	Children_(3_yrs)-Epithelial-club_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CYP2A6 CYP2A7 CYP2B6 TMC5	2.30e-05	191	39	4	23776c7302cead3881b39127398f3b3e0d27885e
ToppCell	IPF-Epithelial-Club\|World / Disease state, Lineage and Cell class	CYP2A6 CYP2A7 CYP2B6 TMC5	2.30e-05	191	39	4	3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954
ToppCell	NS-critical-d_16-33-Epithelial-Secretory-diff\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CYP2A7 CYP2A13 CYP2B6 TMC5	2.35e-05	192	39	4	02b11233b4da2d85b96498b3c6e22e3a31b3d049
ToppCell	Control-Epithelial-Club\|Control / Disease state, Lineage and Cell class	CYP2A6 CYP2A7 CYP2B6 TMC5	2.35e-05	192	39	4	d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16
ToppCell	Epithelial-club_cell\|World / Lineage, Cell type, age group and donor	CYP2A6 CYP2A7 CYP2B6 TMC5	2.40e-05	193	39	4	2bdd09004fa433550958ec42ba4b06271a4aaf7c
ToppCell	Goblet\|World / shred by cell class for turbinate	KDELR2 CYP2A6 CYP2A13 CYP2B6	2.45e-05	194	39	4	03b62e7cff5e7a6e7bd7d9dda273c74bf9c1f42e
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-Secretory/RAS-RAS\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CYP2A6 CYP2A7 CYP2B6 TMC5	2.45e-05	194	39	4	a58841b34efe673671a9a059238e044a7254b279
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-Secretory/RAS\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CYP2A6 CYP2A7 CYP2B6 TMC5	2.45e-05	194	39	4	0cd4363627acd419e00d6d32f6dce10430aa6487
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CYP2A6 CYP2A7 CYP2B6 SPNS2	2.50e-05	195	39	4	dccc32fcf772e2504de7f663ef0a5bd8e23e92fc
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Club\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CYP2A6 CYP2A7 CYP2B6 TMC5	2.50e-05	195	39	4	b9e8f405f6d837bb39b615836d3e2df349737c0e
ToppCell	normal_Lung-Epithelial_cells-Club\|normal_Lung / Location, Cell class and cell subclass	CYP2A6 CYP2A7 CYP2A13 TMC5	2.50e-05	195	39	4	b46544ad5af04f4dbc2643637caa3d2d50d922ae
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-Club\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	CYP2A6 CYP2A7 CYP2A13 CYP2B6	2.55e-05	196	39	4	4e4c632db73b1340d80bf40a7657cb4821084d3c
ToppCell	Bronchial_Biopsy-Epithelial-Club\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	KDELR2 CYP2A13 CYP2B6 TMC5	2.55e-05	196	39	4	057d150bdf0cad959fd03ec2d1560a96ba03fae9
ToppCell	Bronchial_Biopsy-Epithelial-Club\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	KDELR2 CYP2A13 CYP2B6 TMC5	2.60e-05	197	39	4	3f5dfa892a1f631b96eeb6f4cfc284aee51d1ce6
ToppCell	Biopsy_Control_(H.)-Epithelial-SCGB3A2+_SCGB1A1+\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	CYP2A6 CYP2A7 CYP2A13 TMC5	2.65e-05	198	39	4	a3d4b6e4259ded2193d94d2ff6d48cf67214fc35
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Club\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CYP2A6 CYP2A13 CYP2B6 TMC5	2.65e-05	198	39	4	5d57acbe0d245f8bd217eeea07af060092898fbd
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CYP2A6 CYP2A13 CYP2B6 TMC5	2.71e-05	199	39	4	1e693d7bb481bf03a943b460a69787229625d7b1
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CYP2A6 CYP2A7 CYP2B6 TMC5	2.71e-05	199	39	4	a8bfc0b93ad9968cf52a25be86995ffe436bd636
ToppCell	distal-1-Epithelial-Club\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CYP2A6 CYP2A7 CYP2A13 TMC5	2.71e-05	199	39	4	8f0a72a95d0310ef2324c6975495c294b5a47cc8
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Transitional_AT2\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CYP2A6 CYP2A7 CYP2B6 TMC5	2.71e-05	199	39	4	b44d74895846e2ac144438b73e0ca91e3949c16c
ToppCell	Biopsy_IPF-Epithelial-SCGB3A2+_SCGB1A1+\|Biopsy_IPF / Sample group, Lineage and Cell type	CYP2A6 CYP2A13 CYP2B6 TMC5	2.71e-05	199	39	4	c6150f5fe2ce4466149a4d553acb907034a72efb
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Transitional_AT2-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CYP2A6 CYP2A7 CYP2B6 TMC5	2.71e-05	199	39	4	4b374a5de82b4614d3d8a00202ea6cb8f1fd8104
ToppCell	Parenchyma_Control_(B.)-Epithelial-TX-Transitional_AT2\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	CYP2A6 CYP2A7 CYP2B6 TMC5	2.71e-05	199	39	4	9e8231c9007d8d963805a4c99e0905538ceb9b60
ToppCell	distal-Epithelial-Club-1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CYP2A6 CYP2A7 CYP2A13 TMC5	2.71e-05	199	39	4	685cefbe6ff5db8b578e50b5849524ac2f347d0c
ToppCell	Control-Endothelial-Endothelial-Activated_Gen_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	B3GNT5 SPNS2 HDX	1.62e-04	121	39	3	a5962d1c476e6966870832b72d511607e047248b
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MYH4 ANO5 OPRM1	1.78e-04	125	39	3	d05556ea185c15815a4f8643f1c01185badbeece
ToppCell	TCGA-Bile_Duct-Solid_Tissue_Normal-Bile_duct_normal_tissue-Bile_duct_normal_tissue-4\|TCGA-Bile_Duct / Sample_Type by Project: Shred V9	SLCO1B3 CYP2A7 CYP39A1	2.48e-04	140	39	3	744bfab59601efb23450a9bc87bcf541f77ad6b2
ToppCell	TCGA-Bile_Duct-Solid_Tissue_Normal-Bile_duct_normal_tissue\|TCGA-Bile_Duct / Sample_Type by Project: Shred V9	SLCO1B3 CYP2A7 CYP39A1	2.48e-04	140	39	3	bad9aa342bd5244263873936b55cbb95f69bdb5a
ToppCell	TCGA-Bile_Duct-Solid_Tissue_Normal\|TCGA-Bile_Duct / Sample_Type by Project: Shred V9	SLCO1B3 CYP2A7 CYP39A1	2.48e-04	140	39	3	2c35c7d8b7e1101d1b74d7ce3da2364c5602c846
ToppCell	TCGA-Bile_Duct-Solid_Tissue_Normal-Bile_duct_normal_tissue-Bile_duct_normal_tissue\|TCGA-Bile_Duct / Sample_Type by Project: Shred V9	SLCO1B3 CYP2A7 CYP39A1	2.48e-04	140	39	3	deb9d97f1260fe1c4ad4ec3e1ecb111d79f13058
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MYH4 ANO5 OPRM1	2.70e-04	144	39	3	71107275767a0728541a3695715c44874b3e5efc
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Mucinous_Carcinoma-1\|TCGA-Breast / Sample_Type by Project: Shred V9	CYP2A6 CYP2A7 CYP2A13	2.75e-04	145	39	3	1e52e3c615b49e7388cd58a04e74cafac9552447
ToppCell	droplet-Liver-Hepatocytes-24m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLCO1B3 ITGAD KLKB1	2.75e-04	145	39	3	f142b86d4da5b71c189da46cbc4beebdc387ffee
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH2 URB1 TMEM121B	3.35e-04	155	39	3	c58a5fb8d853f12204e961d633e83452eb12a659
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH2 URB1 TMEM121B	3.35e-04	155	39	3	9cb8c42c2e451b2d4dcd7154a4b1bfd21bbb7ea8
ToppCell	Children_(3_yrs)-Epithelial-basal_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CYP2A6 CYP2A7 CYP2B6	3.47e-04	157	39	3	6ee2692f705bdd93ba523dffaf2f0cd921b47e28
ToppCell	droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLCO1B3 CYP39A1 KLKB1	3.67e-04	160	39	3	c42bcc6c7d113f0db43febb088b75ca4ac7cb7a3
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MYH4 ANO5 OPRM1	3.74e-04	161	39	3	dccb61d5e17a8f1c6d1fc146ee389f567659a0f0
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MYH2 TMC2 KLKB1	3.81e-04	162	39	3	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	343B-Myeloid-Macrophage-SPP1+_Macrophage_3\|343B / Donor, Lineage, Cell class and subclass (all cells)	B3GNT5 KLKB1 TMEM121B	3.81e-04	162	39	3	0acb8f7b51bf422d4f4f8e99bd10360163ae4eb7
ToppCell	Club_cells-Donor_05\|World / lung cells shred on cell class, cell subclass, sample id	CYP2A6 CYP2A13 CYP2B6	3.95e-04	164	39	3	4e25e6362ef793b08de2f4d1dccb6b1fc9c072a5
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLXNA4 ANO5 OPRM1	4.09e-04	166	39	3	548d0d6c0ffd564036ddba78620734220ebb73d7
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLXNA4 ANO5 OPRM1	4.09e-04	166	39	3	80e164a89d22098cabe4a99a78283ba69ea0561e
ToppCell	Club_cells-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	CYP2A6 CYP2A13 TMC5	4.16e-04	167	39	3	dbdaaeb3bd9139cb008d9fe24ec031fc5628f136
ToppCell	droplet-Liver-HEPATOCYTES-1m-Epithelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLCO1B3 CYP39A1 KLKB1	4.23e-04	168	39	3	b98af4043dfa5dfa4413e482879fad88de484675
ToppCell	droplet-Liver-HEPATOCYTES-1m-Epithelial-hepatocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLCO1B3 CYP39A1 KLKB1	4.23e-04	168	39	3	073b53d4cee6bc8c5c6fce51cf6cd9c316478f69
ToppCell	droplet-Liver-HEPATOCYTES\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLCO1B3 CYP39A1 KLKB1	4.31e-04	169	39	3	f195467438c589f87224bde7da720dea072d110c
ToppCell	droplet-Liver-HEPATOCYTES-1m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLCO1B3 CYP39A1 KLKB1	4.31e-04	169	39	3	7785cab967a33560830c394c918d6ce625103858
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLXNA4 TMC5 KLKB1	4.31e-04	169	39	3	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MYH4 ANO5 OPRM1	4.38e-04	170	39	3	8ab67e2b6e30fdf9e9a2c02e31d4df34e751a3ed
ToppCell	cellseq2-Epithelial-Epithelial_Glandular-Goblet-Goblet\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CYP2A7 CYP2A13 CYP2B6	4.46e-04	171	39	3	25c1979e972c959e1ce4c57804f976f53a247ad7
ToppCell	cellseq2-Epithelial-Epithelial_Glandular-Goblet\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CYP2A7 CYP2A13 CYP2B6	4.46e-04	171	39	3	fe27bf581c75ef33c2848878e51ed16b275a4c8e
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CTLA4 NF1 B3GNT5	4.53e-04	172	39	3	eee45759284baa3ed77da6a5fbcc4f8f6c553106
ToppCell	3'-Child04-06-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CYP39A1 KLKB1 HDX	4.61e-04	173	39	3	85083b9ce20351dd69aa2327ad087b848b4307ff
ToppCell	COVID-19-kidney-PCT-S3-2\|kidney / Disease (COVID-19 only), tissue and cell type	SLCO1B3 CYP2A6 CYP2B6	4.69e-04	174	39	3	5aa2fb631505600f37d2b87b02def7be139dc262
ToppCell	TCGA-Colorectal-Recurrent_Tumor\|TCGA-Colorectal / Sample_Type by Project: Shred V9	CYP2A6 CYP2A7 KLKB1	4.77e-04	175	39	3	7f74961436f88c0e380819095e6104489914d765
ToppCell	TCGA-Colorectal-Recurrent_Tumor-Colorectal_Adenocarcinoma\|TCGA-Colorectal / Sample_Type by Project: Shred V9	CYP2A6 CYP2A7 KLKB1	4.77e-04	175	39	3	bee8f31f036dfcf9fc6ed29156554771a9ee3c60
ToppCell	10x5'v1-week_14-16-Myeloid_macrophage-stroma-monocytoid_macrophage\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	GPR137B CTLA4 ITGAD	4.93e-04	177	39	3	945b2d0723a0a35c767604ae607d2c2d53bf0c82
ToppCell	nucseq-Epithelial-Epithelial_Airway-Secretory/RAS\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CYP2A7 URB1 TMC5	4.93e-04	177	39	3	779ba86f53650772755b52460be03f18bb204e55
ToppCell	nucseq-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CYP2A7 URB1 TMC5	4.93e-04	177	39	3	0f210cfb61b873c5fd77dc17eadf4d017306500e
ToppCell	TCGA-Liver-Solid_Tissue_Normal\|TCGA-Liver / Sample_Type by Project: Shred V9	SLCO1B3 CYP2B6 CYP39A1	5.09e-04	179	39	3	7046f0a426e45fe1b41a25721ee1e33f6fc7f9e3
ToppCell	TCGA-Liver-Solid_Tissue_Normal-Liver\|TCGA-Liver / Sample_Type by Project: Shred V9	SLCO1B3 CYP2B6 CYP39A1	5.09e-04	179	39	3	0e22e840f43ca81a7543dcf33ec17a741cdf7f37
ToppCell	TCGA-Liver-Solid_Tissue_Normal-Liver-Liver_normal_tissue\|TCGA-Liver / Sample_Type by Project: Shred V9	SLCO1B3 CYP2B6 CYP39A1	5.09e-04	179	39	3	17ba1eedb6ebf039d3b11d099351d0ac6363c8d1
ToppCell	TCGA-Liver-Solid_Tissue_Normal-Liver-Liver_normal_tissue-2\|TCGA-Liver / Sample_Type by Project: Shred V9	SLCO1B3 CYP2B6 CYP39A1	5.09e-04	179	39	3	a20bb3ace5be10c5aef330e9268c0ba55f8fee23
ToppCell	droplet-Limb_Muscle-nan-21m-Mesenchymal-skeletal_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH2 MYH4 HHATL	5.18e-04	180	39	3	cea62fc006d68c3815c88bf17ec2617d7e41c3d2
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PLXNA4 CYP2B6 TMC5	5.18e-04	180	39	3	b509c7d6bdfba672065fb722874bdc68de72ba1c
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CYP2B6 TMC5 SPNS2	5.35e-04	182	39	3	215c303df42f13597b2c7a95cb157c6bc7aca9a1
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_2\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	BPNT2 CTLA4 ARMH3	5.43e-04	183	39	3	310ad42b2b5d8ddd01d3a12db338f80ac1f5d08e
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	BPNT2 CTLA4 ARMH3	5.43e-04	183	39	3	fef51dcf180e6d4e136362c7e140ec5ef372e6d0
ToppCell	CV-Healthy-7\|Healthy / Virus stimulation, Condition and Cluster	URB1 ALG10B ALG10	5.61e-04	185	39	3	1979d189c204f4c2893e3170a514ee7d5523406c
ToppCell	3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-Lymphoid_DC\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GPR137B ITGAD OPRM1	5.61e-04	185	39	3	48de4d9fad55077732bf64eca4919103ecbc1512
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CYP2A6 CYP2A7 CYP2B6	5.78e-04	187	39	3	f5a202d5f8eb57b57d80815ce98774e04c387383
ToppCell	wk_08-11-Epithelial-Proximal_epithelial-Proximal_secretory_2\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	CYP2A6 CYP2A13 TMC5	5.87e-04	188	39	3	07705bed928683470a52c8ccfa40ffb9a0971318
ToppCell	IPF-Epithelial-Club\|IPF / Disease state, Lineage and Cell class	CYP2A6 CYP2B6 TMC5	5.97e-04	189	39	3	f3fcef008ef252b29ac6d567fef27f9acf9cd70f
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CYP2A6 CYP2A13 TMC5	6.06e-04	190	39	3	2fdc024d3d673a0134b74b4c5a63afe924995730
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CYP2A13 CYP2B6 TMC5	6.15e-04	191	39	3	14851529025cfc2b665f71ebad04150ec543da7a
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CYP2A13 CYP2B6 TMC5	6.15e-04	191	39	3	e14b22e882ac92acf8c8b6ee997ef8e799c7a8d5
ToppCell	18-Distal-Epithelial-Secretory_progenitor\|Distal / Age, Tissue, Lineage and Cell class	CYP2A6 CYP2A7 CYP2A13	6.24e-04	192	39	3	9fae988ecd2ef1231bfd42a678a4903517694cbe
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-Club\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CYP2A13 CYP2B6 TMC5	6.24e-04	192	39	3	044c7ae56da17cacf2705efa8ac2c8aeba6cfeee
ToppCell	cellseq-Epithelial-Epithelial_Glandular-Goblet\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CYP2A13 CYP2B6 TMC5	6.34e-04	193	39	3	71bf8fb5314b79cb30f4eb9c8459b21f10cd6d35
ToppCell	cellseq-Epithelial-Epithelial_Alveolar-Secretory/RAS-RAS\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CYP2A6 CYP2A7 TMC5	6.34e-04	193	39	3	525e0de0f25f3308daf49e7d4c8774562f1f40ad
ToppCell	cellseq-Epithelial-Epithelial_Alveolar-Secretory/RAS\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CYP2A6 CYP2A7 TMC5	6.34e-04	193	39	3	2d18f39615043dfbff120a00f6540ffa93082c83
ToppCell	Club_cells\|World / lung cells shred on cell class, cell subclass, sample id	CYP2A6 CYP2A7 TMC5	6.34e-04	193	39	3	9d3165dc5763a07a7d873f497624d9d6528fa2db
Drug	propoxyphene	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1 OPRL1 OPRM1	1.98e-11	67	39	7	CID000010100
Drug	NSC35549	CYP2A6 CYP2A7 CYP2A13 OPRL1 OPRM1	2.91e-10	22	39	5	CID000411697
Drug	2'-methoxyacetophenone	CYP2A6 CYP2A7 CYP2A13	4.65e-09	3	39	3	CID000068481
Drug	polybrominated biphenyl	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	1.17e-08	44	39	5	CID000042948
Drug	9-hydroxybenzo(a)pyrene	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	3.05e-08	53	39	5	CID000028598
Drug	BP-4,5-oxide	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	6.27e-08	61	39	5	CID000037786
Drug	chlorzoxazone	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	7.39e-08	63	39	5	CID000002733
Drug	piperonyl butoxide	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	1.01e-07	67	39	5	CID000005794
Drug	C14845	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.25e-07	27	39	4	CID011954064
Drug	BP-9,10-oxide	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.25e-07	27	39	4	CID000037456
Drug	Brn 4136738	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.25e-07	27	39	4	CID000050331
Drug	4-bromophenol	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CTLA4	1.26e-07	70	39	5	CID000007808
Drug	carteolol	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	1.45e-07	72	39	5	CID000002583
Drug	9-OH-BaP-4,5-oxide	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.46e-07	28	39	4	CID000115064
Drug	7-hydroxycoumarin	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	1.79e-07	75	39	5	CID005281426
Drug	debrisoquine	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	1.79e-07	75	39	5	CID000002965
Drug	11-H-14,15-EETA	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.95e-07	30	39	4	CID011954058
Drug	19-hydroxytestosterone	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.95e-07	30	39	4	CID000150968
Drug	trimipramine	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	2.47e-07	80	39	5	CID000005584
Drug	BP-7,8-oxide	CYP2A6 CYP2A7 CYP2A13 CYP2B6	2.55e-07	32	39	4	CID000037455
Drug	norbuprenorphine	CYP2A6 CYP2B6 OPRL1 OPRM1	2.90e-07	33	39	4	CID000114976
Drug	12(13)-EpOME	CYP2A6 CYP2A7 CYP2A13 CYP2B6	3.28e-07	34	39	4	CID000001416
Drug	TCEO	CYP2A6 CYP2A7 CYP2A13 CYP2B6	3.28e-07	34	39	4	CID000028167
Drug	AC1O5XSP	CYP2A6 CYP2A7 CYP2A13 CYP2B6	3.28e-07	34	39	4	CID006442739
Drug	diosmetin	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	3.35e-07	85	39	5	CID005281612
Drug	AC1L1CJI	CYP2A6 CYP2A7 CYP2A13 CYP2B6	3.70e-07	35	39	4	CID000001929
Drug	mephenytoin	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	3.99e-07	88	39	5	CID000004060
Drug	15-H-11,12-EETA	CYP2A6 CYP2A7 CYP2A13 CYP2B6	4.16e-07	36	39	4	CID011954042
Drug	AC1L3NGJ	CYP2A6 CYP2A7 CYP2A13 CYP2B6	4.16e-07	36	39	4	CID000092121
Drug	AC1L1ILY	MYH2 CYP2A6 OPRL1 OPRM1	5.20e-07	38	39	4	CID000004635
Drug	tienilic acid	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	5.26e-07	93	39	5	CID000038409
Drug	lansoprazole	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	5.26e-07	93	39	5	CID000003883
Drug	11,14,15-THET	CYP2A6 CYP2A7 CYP2A13 CYP2B6	5.79e-07	39	39	4	CID006439531
Drug	bromobenzene	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	6.49e-07	97	39	5	CID000007961
Drug	PCB 77	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	6.83e-07	98	39	5	CID000036187
Drug	AC1L1KIN	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	7.56e-07	100	39	5	CID000005516
Drug	D-702	CYP2A6 CYP2A13 CYP2B6	7.59e-07	11	39	3	CID000054077
Drug	11,12,15-trihydroxyeicosatrienoic acid	CYP2A6 CYP2A7 CYP2A13 CYP2B6	7.85e-07	42	39	4	CID006439610
Drug	Sparteinum	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	7.94e-07	101	39	5	CID000003966
Drug	naphthalene-1,2-dihydrodiol	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.04e-06	45	39	4	CID000000362
Drug	C14802	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.24e-06	47	39	4	CID011954053
Drug	d 6-20	CYP2A6 CYP2A13 CYP2B6	1.31e-06	13	39	3	CID000161569
Drug	C14800	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.35e-06	48	39	4	CID011954051
Drug	nitro-L	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.35e-06	48	39	4	CID000006849
Drug	proadifen hydrochloride	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	1.45e-06	114	39	5	CID000004910
Drug	19-HETE	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.47e-06	49	39	4	CID006439528
Drug	bromobenzene-3,4-oxide	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.47e-06	49	39	4	CID000108121
Drug	bromobenzene-2,3-oxide	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.60e-06	50	39	4	CID003036760
Drug	6-hydroxymelatonin	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.60e-06	50	39	4	CID000001864
Drug	1,1-dichloroethylene epoxide	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.60e-06	50	39	4	CID000119521
Drug	AC1Q7AUJ	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	1.65e-06	117	39	5	CID000003303
Drug	N-nitrosomethylaniline	CYP2A6 CYP2A7 CYP2A13	1.67e-06	14	39	3	CID000011957
Drug	AC1Q7BBT	SLCO1B3 CYP2B6 CYP39A1	1.67e-06	14	39	3	CID000086545
Drug	8-MOP	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	1.72e-06	118	39	5	CID000004114
Drug	naphthalene epoxide	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.73e-06	51	39	4	CID000108063
Drug	benzphetamine	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	1.79e-06	119	39	5	CID000002341
Drug	naphthalene	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	2.11e-06	123	39	5	CID000000931
Drug	dichloroacetaldehyde	CYP2A6 CYP2A7 CYP2A13 CYP2B6	2.19e-06	54	39	4	CID000006576
Drug	chloroacetyl chloride	CYP2A6 CYP2A7 CYP2A13 CYP2B6	2.35e-06	55	39	4	CID000006577
Drug	hexobarbital	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	2.47e-06	127	39	5	CID000003608
Drug	chloral hydrate	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	2.66e-06	129	39	5	CID000002707
Drug	1,2-dihydroxynaphthalene	CYP2A6 CYP2A7 CYP2A13 CYP2B6	2.72e-06	57	39	4	CID000011318
Drug	nicotine imine	CYP2A6 CYP2A13	2.86e-06	2	39	2	ctd:C034629
Drug	propargyl ether	CYP2A6 CYP2A13	2.86e-06	2	39	2	ctd:C531209
Drug	alpha-nicotyrine	CYP2A6 CYP2A13	2.86e-06	2	39	2	ctd:C008615
Drug	verbenone	CYP2A6 CYP2B6	2.86e-06	2	39	2	ctd:C052875
Drug	Hempa	CYP2A6 CYP2A13	2.86e-06	2	39	2	ctd:D006492
Drug	N-nitrosoguvacoline	CYP2A6 CYP2A13	2.86e-06	2	39	2	ctd:C036676
Drug	bromoacetaldehyde	CYP2A6 CYP2A7 CYP2A13 CYP2B6	2.92e-06	58	39	4	CID000105131
Drug	1,1-dichloroethylene	CYP2A6 CYP2A7 CYP2A13 CYP2B6	3.34e-06	60	39	4	CID000006366
Drug	aminoglutethimide	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	3.58e-06	137	39	5	CID000002145
Drug	AC1L1QMT	CYP2A6 CYP2B6 OPRL1	3.72e-06	18	39	3	CID000008270
Drug	D 703	CYP2A6 CYP2A13 CYP2B6	3.72e-06	18	39	3	CID000054088
Drug	coumarin	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	3.84e-06	139	39	5	CID000000323
Drug	aniline	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	4.27e-06	142	39	5	CID000006115
Drug	D 617	CYP2A6 CYP2A13 CYP2B6	4.42e-06	19	39	3	CID000093168
Drug	NSC9700	MYH2 CYP2A6 CYP2A7 MYH4 CYP2A13 CYP2B6 CYP39A1 KLKB1	5.05e-06	578	39	8	CID000005408
Drug	NSC76436	CYP2A6 OPRL1 OPRM1	5.19e-06	20	39	3	CID000002828
Drug	5,6-epoxyeicosatrienoic acid	CYP2A6 CYP2A7 CYP2A13 CYP2B6	5.53e-06	68	39	4	CID000001778
Drug	8(9)-EET	CYP2A6 CYP2A7 CYP2A13 CYP2B6	5.86e-06	69	39	4	CID000001901
Drug	methoxyresorufin	CYP2A6 CYP2A13 CYP2B6 CYP39A1	5.86e-06	69	39	4	CID000119220
Drug	nifedipine	MYH2 CYP2A6 CYP2A7 MYH4 CYP2A13 CYP2B6 CYP39A1	5.91e-06	415	39	7	CID000004485
Drug	1h1q	CYP2A6 CYP2A7 CYP2A13 CYP2B6	6.21e-06	70	39	4	CID000001540
Drug	1-aminobenzotriazole	CYP2A6 CYP2A13 CYP2B6 CYP39A1	6.57e-06	71	39	4	CID000001367
Drug	1,2-dibromoethane	CYP2A6 CYP2A7 CYP2A13 CYP2B6	6.57e-06	71	39	4	CID000007839
Drug	2,2,2-trichloroethanol	CYP2A6 CYP2A7 CYP2A13 CYP2B6	7.35e-06	73	39	4	CID000008259
Drug	chloral	CYP2A6 CYP2A7 CYP2A13 CYP2B6	7.35e-06	73	39	4	CID000006407
Drug	2-propyl-4-pentenoic acid	CYP2A6 CYP2B6	8.57e-06	3	39	2	ctd:C045022
Drug	5-hydroxyvalproate	CYP2A6 CYP2B6	8.57e-06	3	39	2	ctd:C091208
Drug	4-hydroxyvalproate	CYP2A6 CYP2B6	8.57e-06	3	39	2	ctd:C091207
Drug	hexafluoron	CYP2A6 CYP2B6	8.57e-06	3	39	2	ctd:C058039
Drug	paraoxon	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	8.62e-06	164	39	5	CID000009395
Drug	C20H32O4	CYP2A6 CYP2A7 CYP2A13 CYP2B6	9.57e-06	78	39	4	CID000001440
Drug	BP-7,8-diol	CYP2A6 CYP2A7 CYP2A13 CYP2B6	9.57e-06	78	39	4	CID000025892
Drug	felodipine	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	9.97e-06	169	39	5	CID000003333
Drug	Tranylcypromine	CYP2A6 CYP2A13 CYP2B6	1.04e-05	25	39	3	ctd:D014191
Drug	aminopyrine	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	1.06e-05	171	39	5	CID000006009
Drug	4-nitrophenol	CYP2A6 CYP2A13 CYP2B6 SACS CYP39A1	1.25e-05	177	39	5	CID000000980
Drug	rifampicin	SLCO1B3 CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	1.26e-05	306	39	6	CID005381226
Drug	metyrapone	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP39A1	1.32e-05	179	39	5	CID000004174
Disease	nicotine metabolite ratio	CYP2A6 CYP2A7 CYP2B6	4.30e-07	12	38	3	EFO_0007794
Disease	caffeine metabolite measurement	CYP2A6 CYP2A7 CYP2B6	1.88e-06	19	38	3	EFO_0007872
Disease	Long Qt Syndrome 2	ALG10B ALG10	4.84e-06	3	38	2	C3150943
Disease	CHGA cleavage product measurement	TMC2 KLKB1	1.61e-05	5	38	2	EFO_0007909
Disease	nonsyndromic deafness (implicated_via_orthology)	ALG10B ALG10	2.41e-05	6	38	2	DOID:0050563 (implicated_via_orthology)
Disease	Morphine Abuse	OPRL1 OPRM1	3.38e-05	7	38	2	C0600272
Disease	Morphine Dependence	OPRL1 OPRM1	3.38e-05	7	38	2	C0026552
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH2 MYH4	7.22e-05	10	38	2	DOID:0110454 (implicated_via_orthology)
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH2 MYH4	7.22e-05	10	38	2	DOID:0111269 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH2 MYH4	7.22e-05	10	38	2	DOID:0080719 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH2 MYH4	7.22e-05	10	38	2	DOID:0111602 (implicated_via_orthology)
Disease	inclusion body myositis (implicated_via_orthology)	MYH2 MYH4	7.22e-05	10	38	2	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH2 MYH4	7.22e-05	10	38	2	DOID:0111605 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH2 MYH4	7.22e-05	10	38	2	DOID:0080326 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH2 MYH4	7.22e-05	10	38	2	DOID:0111596 (implicated_via_orthology)
Disease	distal myopathy (implicated_via_orthology)	MYH2 MYH4	1.06e-04	12	38	2	DOID:11720 (implicated_via_orthology)
Disease	myotonia congenita (implicated_via_orthology)	MYH2 MYH4	1.06e-04	12	38	2	DOID:2106 (implicated_via_orthology)
Disease	TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding)	CYP2A6 CYP2B6	1.06e-04	12	38	2	C1861063
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH2 MYH4	1.25e-04	13	38	2	DOID:397 (implicated_via_orthology)
Disease	Hepatitis C	CYP2A6 OPRM1	1.68e-04	15	38	2	C0019196
Disease	distal arthrogryposis (implicated_via_orthology)	MYH2 MYH4	1.68e-04	15	38	2	DOID:0050646 (implicated_via_orthology)
Disease	acute myeloid leukemia (is_implicated_in)	CYP2B6 CTLA4 NF1	1.75e-04	84	38	3	DOID:9119 (is_implicated_in)
Disease	lupus nephritis (is_implicated_in)	CTLA4 KLKB1	2.44e-04	18	38	2	DOID:0080162 (is_implicated_in)
Disease	sciatic neuropathy (biomarker_via_orthology)	MYH4 NF1 OPRL1	2.84e-04	99	38	3	DOID:11446 (biomarker_via_orthology)
Disease	Alcoholic Intoxication, Chronic	CYP2A13 CYP2B6 OPRL1 OPRM1	3.85e-04	268	38	4	C0001973
Disease	smoking behavior	PLXNA4 CYP2A6 CYP2A7 CYP2B6	9.49e-04	341	38	4	EFO_0004318
Disease	testosterone measurement	SLCO1B3 MYH2 URB1 NF1 SPNS2 OPRL1 OPRM1	1.08e-03	1275	38	7	EFO_0004908

Protein segments in the cluster

Peptide	Gene	Start	Entry
FMLSTYQTDFILVLK	CASTOR3	126	Q8NAP1
LKMLNLFYQTFSLIS	CYP2B6	196	P20813
EYESSLTLKMFLFQF	ANO5	551	Q75V66
FYLKNLVMTTLNLFI	CYP2A6	286	P11509
NLLITFLKYSSIVMQ	ARMH3	366	Q5T2E6
RKILQFLLAYSMSFK	ALG10B	231	Q5I7T1
FLLAYSMSFKNLSML	ALG10B	236	Q5I7T1
TLLTTLMFFNTKYFL	QRICH1	621	Q2TAL8
KVLSLFYSLFNPMLN	OR2A14	271	Q96R47
MKTATNIYIFNLALA	OPRM1	101	P35372
YFKLQTFVRSLILAM	HDX	626	Q7Z353
MYNLVSLNSLKFTEL	HHATL	441	Q9HCP6
AFLTLYNLTQDMKYL	LANCL1	331	O43813
FANILLYIQRTKSMF	EIF3L	336	Q9Y262
MSLIINTFYSNKEIF	HSP90AB4P	1	Q58FF6
SQLYYFMTLTLSDLK	PLXNA4	946	Q9HCM2
LYQKSAMKTLAQLFS	MYH2	611	Q9UKX2
LINKLDFAMSTYLLS	PI4KA	881	P42356
VLSNRKMFYLLKTAF	BPNT2	111	Q9NX62
QKVLSLFYSLFNPML	OR2A5	271	Q96R48
LFALMQYSNLLKIHF	ITGAD	186	Q13349
FVDSFYNLTLKLLMQ	B3GNT5	161	Q9BYG0
FYLKNLVMTTLNLFF	CYP2A13	286	Q16696
FYLKNLMMSTLNLFI	CYP2A7	286	P20853
MILFKQATYFISLFA	KLKB1	1	P03952
FYSFLLTAVSLSKML	CTLA4	176	P16410
LYPVTVNMLFNKSLF	CYP39A1	166	Q9NYL5
DLFMNTLYLKYSNIL	SACS	3186	Q9NZJ4
LFTSFISLYNTSMKV	KDELR2	51	P33947
KMKTATNIYIFNLAL	OPRL1	81	P41146
MNLDSFFSFLLKSLI	OR52L2P	1	Q8NGH6
FFSFLLKSLIMALSN	OR52L2P	6	Q8NGH6
LMNLYFTQVIFKAKS	GPR137B	131	O60478
SYQQPLSIFMLKNLF	TMEM121B	491	Q9BXQ6
LFTKNTRTLMLSVFY	SPNS2	221	Q8IVW8
LYQKSAMKTLAFLFS	MYH4	611	Q9Y623
TFLKMLLTAVQLLYS	URB1	1446	O60287
RKILQFLLAYSMSFK	ALG10	231	Q5BKT4
FLLAYSMSFKNLSML	ALG10	236	Q5BKT4
SFLTSMISFLFQLLY	SLCO1B3	411	Q9NPD5
QLFLKYFTLFMNLLN	NF1	1101	P21359
LSFLLNLILGMKFTY	TMEM225	76	Q6GV28
KLTFNQLLTRFSAYM	TMC5	606	Q6UXY8
LLMFLAIYYLNSVSK	TMC2	766	Q8TDI7